0.10%QQQQ 44.63 
0.18%XLF 19.94 0.35%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK (AP) - Shares of large-cap biotechnology companies opened mostly higher Friday, as positive data abstracts from Genentech and ImClone started to be released ahead of the American Society of Clinical Oncology Conference in Chicago.
The broader market slipped as investors digested new record highs for oil and a surprising jump in new home construction. In early trading the Dow Jones industrial average is down 6 points at the 12,986 level.
Here's how several key biotechnology stocks are doing Friday:
Celgene Corp., up 66 cents at $59.95.
Amgen Inc., up 6 cents at $42.11.
Biogen Idec Inc., up 27 cents to $63.17.
Genentech Inc., up $1.31, or 2 percent, to $70.14 to $69.48.
I recently read an "advotorial" suggesting silver to be a fantastic investment, and I could not agree more. However, the author was stating that ...
The U.S. has done the least among the world's eight biggest economies to address...
A hedge fund cheat who tried to fake his own death and spent nearly a month as a...
|
Professional Website Design For Corporate - Get a Free Quote Today
Find the most up to date research from leading investment firms to make the most informed investing decisions
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
-0.5
2
